N-acetylmannosamine
- Generic Name
- N-acetylmannosamine
- Drug Type
- Small Molecule
- Chemical Formula
- C8H15NO6
- CAS Number
- 3615-17-6
- Unique Ingredient Identifier
- X80PR7P73R
- Background
N-acetylmannosamine is under investigation for the other of GNE Myopathy.
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis
- First Posted Date
- 2024-10-30
- Last Posted Date
- 2025-05-21
- Lead Sponsor
- National Human Genome Research Institute (NHGRI)
- Target Recruit Count
- 30
- Registration Number
- NCT06664814
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Multi-Center Study of ManNAc for GNE Myopathy
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Leadiant Biosciences, Inc.
- Target Recruit Count
- 54
- Registration Number
- NCT04231266
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
🇺🇸University of Iowa, Iowa City, Iowa, United States
🇺🇸University of Kansas, Medical Center, Kansas City, Kansas, United States
An Open Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy
- First Posted Date
- 2015-01-27
- Last Posted Date
- 2019-04-16
- Lead Sponsor
- National Human Genome Research Institute (NHGRI)
- Target Recruit Count
- 12
- Registration Number
- NCT02346461
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Phase I Clinical Trial of ManNAc in Patients With GNE Myopathy or Hereditary Inclusion Body Myopathy (HIBM)
Phase 1
Completed
- Conditions
- GNE MyopathyHereditary Inclusion Body Myopathy (HIBM)
- Interventions
- First Posted Date
- 2012-07-06
- Last Posted Date
- 2017-10-19
- Lead Sponsor
- National Human Genome Research Institute (NHGRI)
- Target Recruit Count
- 26
- Registration Number
- NCT01634750
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath